For more information about the Michigan Affiliate of the Pancreatic Cancer Action Network (@PanCAN) 💜 visit: facebook.com/share/g/Z7ZFXrE…

This Men's Health Month, visit pancan.org to learn more. 💜

Congress is now writing their annual appropriations bills that fund the agencies and programs that conduct #pancreaticcancer research. 🔬 The key committees with authority over the National Institutes of Health (NIH), National Cancer Institute (NCI) and the Pancreatic Cancer Research Program (PCARP) will be meeting and debating this legislation over the next month. While these debates are happening, Congress needs to hear that you want them to ensure increases are included to propel science and discovery forward to increase survival for all those impacted by pancreatic cancer. Take action now at 🔗 pcan.at/yavvkov4 to advocate for research funding increases with your members of Congress! 💜

Check out our Rogel and Blondy Center leading pancreas cancer researcher, Marina Pasca di Magliano, PhD, recently highlighted in NYT! "Almost everybody thought that it was going to be impossible to make drugs against KRAS." @UMRogelCancer @timofran1 @LyssiotisLab @Pasca_Lab How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough nytimes.com/2026/05/12/healt…

During this week's Hope Into Action: All About Becoming a #PanCANvolunteer session, you'll learn how your involvement, big or small, moves PanCAN's mission to take bold action against the disease. 💜 pancan.org/get-involved/volu…

It is a great day when our team can honor and celebrate a student's long journey. Allison Bischoff defended her PhD thesis, Origins and Developmental Signaling Pathways Dictate the Function of Cancer Associated Fibroblasts in Pancreatic Cancer. Congratulations, Dr. Bischoff, we are so proud of you! @Pasca_Lab @Fil_Bednar @timofran1 @LyssiotisLab @emilylasse

Throughout Mental Health Month, we’re sharing reminders for the #pancreaticcancer community that support, connection and care matter — because you don’t have to carry this alone. 💜

Addressing Mental Health: Five Ways PanCAN Can Help pancan.org/news/addressing-m… @PanCAN

In episode twenty of PancChat, host @AlisynCamerota speaks with @DrLizJaffeeabout the latest advances in #pancreaticcancer research. Dr. Jaffee explores why pancreatic cancer has historically resisted immunotherapy, the promise of cancer vaccines and the emergence of KRAS inhibitors as a new class of targeted therapies — and shares why, after 30 years in the field, she is more optimistic than ever. 💜 Listen on demand at 🔗 bit.ly/42fEexO PancChat is a collaboration between @LetsWinPC and @PanCAN.

When words aren't needed. @PanCANMichigan #PanCANPurpleStride 💜

Announcing PanCAN’s $250 Million All Together We Can Campaign pancan.org/news/announcing-p… @PanCAN

Research Spotlight: Emerging Role of Blood-Based Cancer Detection Tests pancan.org/news/research-spo…

Q&A: Honoring Rita, One Step at a Time pancan.org/stories/qa-honori…

Yesterday’s announcement from @RevMedicines that their RAS inhibitor daraxonrasib extends survival in #pancreaticcancer marks a significant step forward. @PanCAN pancan.org/news/first-ras-in…

PanCAN Statement on Positive Overall Survival Results from Revolution Medicines Phase III Trial pancan.org/press-releases/pa…

Contact our senators and urge them to sign their names in support of dedicated pancreatic cancer research funding. Time is limited — don’t wait! ⏰💜 pcan.at/tsygs5

A new therapy that targets RAS mutations present in more than 90% of patients with pancreatic adenocarcinoma — the most common type of pancreatic cancer — approximately doubles overall survival according to clinical trial results announced today. 🧪 @RevMedicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously treated metastatic #pancreaticcancer. For decades, RAS was considered “undruggable,” meaning that there was no effective way to target RAS. These results greatly expand the potential benefit of targeted therapies for patients with pancreatic cancer. PanCAN Chief Scientific and Medical Officer @ABerkenblit, MD, MMSc, shares, “We are standing at the threshold of groundbreaking treatments for patients with pancreatic cancer. Today’s announcement represents a real opportunity to bring new hope for people facing this disease: hope for more time with family, hope for better quality of life and hope that ongoing and future research may ultimately lead to a cure.” 💜 Next, Revolution Medicines will need to take their data to the U.S. Food and Drug Administration (FDA). If the FDA grants approval for daraxonrasib, it will be made available as a treatment for patients with metastatic pancreatic adenocarcinoma who have been previously treated. For what you need to know about this news, visit 🔗 pcan.at/rjul9sza.

First RAS Inhibitor Extends Survival in Previously Treated Metastatic Pancreatic Adenocarcinoma: What You Need to Know pancan.org/news/first-ras-in…

The Tigers mourn the passing of former manager Phil Garner and share our condolences with his family and loved ones. Garner, a 3x All-Star and World Series Champion during his 16-year playing career, went on to a successful 15-year big league managerial career including 2000-02 with the Tigers, our first manager at Comerica Park.

@PanCANMichigan offers its deepest condolences on the passing of former @tigers manager Phil Garner. A 3x All-Star and World Series champ, "Scrap Iron" left an indelible mark on baseball through his grit and leadership. Our thoughts are with his family freep.com/story/sports/mlb/t…